UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Vagal Nerve Stimulation for Treatment Resistant Major Depression
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Device: gammaCore™
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 5
- Registration Number
- NCT04990687
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
Phase 1
Terminated
- Conditions
- Cholangiocarcinoma
- Interventions
- Drug: Novel combination of chemotherapy and immunotherapy
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 1
- Registration Number
- NCT04989218
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Effect of Manual Wheelchair Propulsion Workload on Speed, Energy Expenditure, and Propulsion Mechanics
Not Applicable
Completed
- Conditions
- Healthy Participants
- Interventions
- Other: Workload of Manual Wheelchair Propulsion
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 11
- Registration Number
- NCT04987177
- Locations
- 🇺🇸
UAB/Lakeshore Research Colaborative Building, Homewood, Alabama, United States
Feasibility of the Mindfulness-Based Stress Reduction Intervention for Black Women Living With HIV Supplement
Not Applicable
Completed
- Conditions
- HIV InfectionsMild Cognitive Impairment
- Interventions
- Other: Usual CareBehavioral: Mindfulness
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT04984681
- Locations
- 🇺🇸
UAB School of Nursing, Birmingham, Alabama, United States
Oxygen Insufflation in Microlaryngoscopies
Not Applicable
Withdrawn
- Conditions
- Hypoxia
- Interventions
- Device: Insufflator oxygen tubing
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT04979533
STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)
Recruiting
- Conditions
- Stroke
- Interventions
- Other: no intervention
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 1500
- Registration Number
- NCT04978480
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Mood Disorders in Head and Neck Cancer Patients
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 205
- Registration Number
- NCT04977271
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
Phase 2
Recruiting
- Conditions
- ICANSLymphoma, Non-HodgkinAcute Lymphoblastic LeukemiaCytokine Release SyndromeMultiple Myeloma
- Interventions
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT04975555
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- Other: Spinal ManipulationOther: Sham Spinal Manipulation
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 26
- Registration Number
- NCT04972929
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
Phase 2
Recruiting
- Conditions
- HypertensionRenin-Angiotensin-Aldosterone SystemNocturnal Blood PressureObesityNatriuretic PeptidesCardiovascular Diseases
- Interventions
- Drug: Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 160
- Registration Number
- NCT04971720
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath